Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor

被引:44
作者
Gelling, RW
Wheeler, MB
Xue, JP
Gyomorey, S
Nian, CL
Pederson, RA
McIntosh, CHS
机构
[1] UNIV BRITISH COLUMBIA, FAC MED, DEPT PHYSIOL, VANCOUVER, BC V6T 1Z3, CANADA
[2] UNIV TORONTO, DEPT PHYSIOL & MED, TORONTO, ON, CANADA
关键词
D O I
10.1210/en.138.6.2640
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The receptors for the two structurally related insulinotropic hormones Glucose-dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) share approximately 40% sequence identity and demonstrate complete specificity for their endogenous ligands, while utilizing similar second messenger pathways. In the current study chimeric GIP-GLP-1 receptors were prepared, and the effect of domain-exchange on ligand binding and adenylyl cyclase activation examined. A chimera (CH-2) consisting of the first 132 amino acids of the external N-terminal (NT) domain bound I-125-GIP with high affinity (27.77 +/- 11.85 nM). However, for receptor coupling to cAMP production it was necessary to extend the NT into the first transmembrane (TM-1) region (CH-3: IC50 = 9.04 +/- 1.07 nM; EC50 = 17.1 +/- 3.5 nM). A chimera which included part of TM-3 (CH-4) demonstrated binding and signalling (IC50 = 8.33 +/- 0.14 nM; EC50 = 467.5 +/- 173.6 pM) similar to the wild type receptor (IC50 = 1.33 +/- 0.19 nM; EC50 = 497.3 +/- 211.7 pM). Surprisingly constructs CH-2 and CH-3, while devoid of detectable I-125-GLP-1 binding, were capable of eliciting GLP-1-specific cAMP production (EC50S CH-2 = 81.4 +/- 19.6 nM; CH-3 = 5.99 +/- 0.68 nM) suggesting that receptor activation is not completely dependent on, high affinity receptor binding. These data clearly demonstrate that the NT domain of the GTP receptor acts as the ligand-specific binding domain and that the first transmembrane domain is important for receptor activation.
引用
收藏
页码:2640 / 2643
页数:4
相关论文
共 19 条
[1]   GLUCAGON-CENTER-DOT-GLUCAGON-LIKE PEPTIDE-I RECEPTOR CHIMERAS REVEAL DOMAINS THAT DETERMINE SPECIFICITY OF GLUCAGON BINDING [J].
BUGGY, JJ ;
LIVINGSTON, JN ;
RABIN, DU ;
YOOWARREN, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (13) :7474-7478
[2]  
CARRUTHERS CJL, 1994, J BIOL CHEM, V269, P29321
[3]  
Combarnous Yves, 1992, Endocrine Reviews, V13, P670, DOI 10.1210/er.13.4.670
[4]   CLONING AND FUNCTIONAL EXPRESSION OF THE HUMAN GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR [J].
DILLON, JS ;
TANIZAWA, Y ;
WHEELER, MB ;
LENG, XH ;
LIGON, BB ;
RABIN, DU ;
YOOWARREN, H ;
PERMUTT, MA ;
BOYD, AE .
ENDOCRINOLOGY, 1993, 133 (04) :1907-1910
[5]   LOCATION OF REGIONS OF THE OPIOID RECEPTOR INVOLVED IN SELECTIVE AGONIST BINDING [J].
FUKUDA, K ;
KATO, S ;
MORI, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (12) :6702-6709
[6]   SUBCUTANEOUS INJECTION OF THE INCRETIN HORMONE GLUCAGON-LIKE PEPTIDE-1 ABOLISHES POSTPRANDIAL GLYCEMIA IN NIDDM [J].
GUTNIAK, MK ;
LINDE, B ;
HOLST, JJ ;
EFENDIC, S .
DIABETES CARE, 1994, 17 (09) :1039-1044
[7]   GLUCAGON-LIKE PEPTIDE-1 - A NEWLY DISCOVERED GASTROINTESTINAL HORMONE [J].
HOLST, JJ .
GASTROENTEROLOGY, 1994, 107 (06) :1848-1855
[8]   CRITICAL CONTRIBUTIONS OF AMINO-TERMINAL EXTRACELLULAR DOMAINS IN AGONIST BINDING AND ACTIVATION OF SECRETIN AND VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTORS - STUDIES OF CHIMERIC RECEPTORS [J].
HOLTMANN, MH ;
HADAC, EM ;
MILLER, LJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) :14394-14398
[9]   ROLE OF THE EXTRACELLULAR REGIONS OF THE PARATHYROID-HORMONE (PTH) PTH-RELATED PEPTIDE RECEPTOR IN HORMONE-BINDING [J].
LEE, CW ;
GARDELLA, TJ ;
ABOUSAMRA, AB ;
NUSSBAUM, SR ;
SEGRE, GV ;
POTTS, JT ;
KRONENBERG, HM ;
JUPPNER, H .
ENDOCRINOLOGY, 1994, 135 (04) :1488-1495
[10]   THE ROLE OF THE FREE CYTOSOLIC CALCIUM LEVEL IN BETA-CELL SIGNAL TRANSDUCTION BY GASTRIC-INHIBITORY POLYPEPTIDE AND GLUCAGON-LIKE PEPTIDE I(7-37) [J].
LU, M ;
WHEELER, MB ;
LENG, XH ;
BOYD, AE .
ENDOCRINOLOGY, 1993, 132 (01) :94-100